COVID-19 pandemic is affecting various areas of health care, including human reproduction. Many women with reproductive failures, during the peri-implantation period and pregnancy, are on the immunotherapy using immune modulators and immunosuppressant due to underlying autoimmune diseases, cellular immune dysfunction, and rheumatic conditions. Many questions have been raised for women with immunotherapy during the COVID-19 pandemic, including infection susceptibility, how to manage women with an increased risk of and active COVID-19 infection. SARS-CoV-2 is a novel virus, and not enough information exists. Yet, we aim to review the data from previous coronavirus outbreaks and current COVID-19 and provide interim guidelines for immunotherapy in women with reproductive failures.

中文翻译：

---

妇女生殖功能衰竭的COVID-19和免疫调节治疗。

COVID-19大流行正在影响卫生保健的各个领域，包括人类生殖。由于潜在的自身免疫性疾病，细胞免疫功能障碍和风湿病，许多在植入前后和怀孕期间生殖衰竭的妇女正在使用免疫调节剂和免疫抑制剂进行免疫治疗。对于在COVID-19大流行期间接受免疫治疗的妇女，已经提出了许多问题，包括感染易感性，如何管理COVID-19感染风险和活动性增加的妇女。SARS-CoV-2是一种新型病毒，没有足够的信息。但是，我们的目的是回顾以前的冠状病毒暴发和当前的COVID-19的数据，并为患有生殖衰竭的妇女提供免疫治疗的临时指南。